NEW YORK, Sept. 07, 2017 (GLOBE NEWSWIRE) — AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the Company will be featured as a presenting company at the Rodman & Renshaw 19th Annual Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The conference is being held on September 11-12, 2017 at the Lotte New York Palace Hotel in New York City.
George Anastassov, MD, DDS, MBA and Chief Executive Officer of AXIM, will present a corporate update at the Conference on September 11 at 5:05-5:30pm ET in Kennedy II. AXIM’s management will also be holding one-on-one meetings with investors at the Conference.
The Global Investment Conference, which will feature more than 300 public and private companies from around the world, with over 2,000 attendees, offers investors sector tracks devoted to Biotechnology & Healthcare, Metals & Mining, CleanTech, Technology and Media …